• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Difference In What Medicare Spends On Cancer Care May Not Affect Survival Rates

Article

Although Medicare spending for patients with advance cancers varies regionally, a new study suggests that those differences are not related to survival rates.

The study, published Tuesday in the Journal of the National Cancer Institute, examined Medicare spending on patients with advanced lung, colorectal, pancreatic, breast, and prostate cancers. Cancer care costs account for approximately 10 percent of Medicare payments and effective treatments to “prolong survival in this population are limited,” the researchers noted.

Read the full story: http://bit.ly/YYtolQ

Source: Kaiser Health News

Related Videos
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Screenshot of an interview with Shaun McKenzie, MD
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Dr Andrew S. Oseran
Dr Maria DeYoreo
Screenshot of an interview with Shaun McKenzie, MD
Dr Maria DeYoreo
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.